How a $300 Mistake Opened a $1 Billion Market
Novo Nordisk, the pharmaceutical giant behind weight-loss blockbusters Ozempic and Wegovy, just let a key patent on semaglutide lapse in Canada because it forgot to pay a routine maintenance fee, the pharmaceutical equivalent of forgetting to renew your car registration.
As a result, generic versions of semaglutide, the active ingredient in both drugs,
» Read more about: How a $300 Mistake Opened a $1 Billion Market »
Read More
								    				
							    			Is Michael Saylor’s Bet Crazy: Bull vs Bear
Microstrategy (NASDAQ:MSTR) and its CEO Michael Saylor are in large part confounding valuation experts worldwide.
The traditional method of valuing a company goes something like this. Analyze the cash flows a company will produce over its lifetime, discount them back to present day, sum them up and arrive at a fair market valuation for the company.
» Read more about: Is Michael Saylor’s Bet Crazy: Bull vs Bear »
Read More
								    				
							    			Why Did NVIDIA Invest In Little-Known AI Stock?
For nearly two years, the stock market has been steadily bidding up companies like NVIDIA and Microsoft that have emerged as front-runners in the AI race. In addition to these mega-cap companies, though, there are also many smaller companies trying to fill niche spaces in the AI market.
One such company is Nebius Group (NASDAQ:NBIS),
» Read more about: Why Did NVIDIA Invest In Little-Known AI Stock? »
Read More
								    				
							    			Is Meta Breaking Out?
Headlines swirled in recent days that Mark Zuckerberg was meeting with President-Elect Donald Trump at Mar-a-Lago.
Some speculated Zuckerberg was going to “bend the knee” while others thought he was looking for an active role in the new administration.
What we haven’t seen anyone discuss yet is whatever conversation did take place in that room appears to have been received well by markets because Meta now seems to be breaking higher.
» Read more about: Is Meta Breaking Out? »
Read More
								    				
							    			I Finally Found an 8% Yielder
Real estate, REITs, dividend stocks, you name it. I’m always looking for new ways to make my money work while I sleep. And one stock I found that’s super interesting for passive income is Main Street Capital (NASDAQ: MAIN).
It has the hallmarks of being one of the best passive income machines I’ve seen,
» Read more about: I Finally Found an 8% Yielder »
Read MoreThe Ivy
								    				
							    			Buffett’s $19 Billion Oil Bet Looks Like a Fortress
It’s the rare oil major that seems built to outlast cycles, keep the dividend flowing, and, as Warren Buffett clearly believes, keep getting stronger.
The yield is about 4.4%, nearly four times what the S&P 500 pays and on paper that looks tempting, but high yields in energy can be a trap. The difference here is Chevron’s payout isn’t balanced on a knife’s edge.
» Read more about: Buffett’s $19 Billion Oil Bet Looks Like a Fortress »
Read MoreThe Spotlight
								    				
							    			2 Recession-Proof Stocks to Beat the 2025 Slowdown
While many economists and investors initially expected 2025 to be another good year, the outlook in America has soured rapidly as steep tariffs and a softer labor market appear set to increase prices and curtail growth.
Recently, JPMorgan Chase analysts raised their predicted recession risk for the year from 30% to 40% due largely to America’s emerging trade wars.
» Read more about: 2 Recession-Proof Stocks to Beat the 2025 Slowdown »
Read MoreThe Daily
Dominion Energy (D) Beats Expectations in Q3 Report
Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!
AI is eating the world—and the machines behind it are ravenous.
Each ChatGPT query, each model update, each robotic breakthrough consumes massive amounts of energy.
» Read more about: Dominion Energy (D) Beats Expectations in Q3 Report »